SE rides Free Fire's momentum as Garena posts 51% bookings growth and eyes strong expansion with new game launches.

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (NASDAQ: AGEN), a leader in immuno-oncology innovation, today announced that its Annual Shareholders Meeting will begin at 10:30 a.m. ET on June 17, 2025, and will be conducted in a virtual format only. Registration for attendees will start at 10:15 a.m. ET. To participate in the Annual Shareholders Meeting, shareholders should visit www.virtualshareholdermeeting.com/AGEN2025 and enter the 16-digit control number found in their proxy mat.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Vestis Corporation (NYSE:VSTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/vestis-corporation-lawsuit-submission-form?prid=152453&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

Pharmacy chain Walgreens and reality star turned entrepreneur Kourtney Kardashian are among those picking over the remaining assets in Rite Aid's bankruptcy, according to two people familiar with the matter.

Adobe Inc (NASDAQ:ADBE) remains a ‘Buy'-rated stock according to analysts at Jefferies, who cited the company's strong product relevance, continued innovation, and compelling valuation. Despite recent underperformance, the analysts noted that Adobe's fundamentals and long-term outlook remain intact.

ATLANTA, June 10, 2025 (GLOBE NEWSWIRE) -- Lucasys, a leading cloud software and service provider for rate-regulated utilities, today announced that its suite of tax applications – including Lucasys Tax Depreciation, Deferred Tax, TBBS, and Copilot – is now available on the SAP® Store, the digital marketplace for SAP and partner offerings. This milestone follows Lucasys' recent partnership within the SAP® PartnerEdge® Open Ecosystem.

UiPath Inc. (NYSE:PATH ) BMO 2025 Virtual Software Conference June 10, 2025 10:00 AM ET Company Participants Ashim Gupta - CFO & COO Conference Call Participants Keith Frances Bachman - BMO Capital Markets Equity Research Keith Frances Bachman Okay. Good morning.

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDQ: URGN) for violations of the federal securities laws on behalf of investors who purchased or acquired UroGen securities between July 27, 2023 and May 15, 2025, inclusive (the “Class Period”).

This stock may not be part of the most exciting stories in the stock market today, both in terms of its business model and price action. While every investor is watching the developments in the artificial intelligence space as closely as ever, the so-called “smart money” is looking elsewhere, this time surrounding the consumer staples sector for its recent picks that could become potential winners.

SNOW launches Standard Warehouse Gen2 with up to 2.1X faster analytics and 1.9X faster execution, which is expected to fuel growth.

Apple is reportedly deepening its relationship with OpenAI while also rolling out new artificial intelligence capabilities. [contact-form-7] The expanded partnership with the ChatGPT maker was one of several AI-related announcements from the tech giant at its 2025 Worldwide Developers Conference (WWDC), Bloomberg reported Monday (June 9).

Yext (YEXT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Snap will launch its first-ever smart glasses for all consumers next year, ratcheting up competition with bigger rival Meta in the wearable technology market.

Despite Novo Nordisk's recent stock slide, strong Q1 FY25 results and strategic initiatives reinforce a "Buy" rating, presenting a continued, albeit tested, investment opportunity for patient investors. Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market, despite revised guidance due to compounded drug impacts. NVO actively combats compounded GLP-1s via legal routes, new patient access programs like $499 Wegovy, and key formulary wins such as CVS exclusivity.

PEP is doubling down on Gatorade and LIFEWTR as it pivots toward wellness to drive future growth.

Uber prepares to test fully self-driving taxis on London's roads, in line with its objective to become a key player in the robotaxi market.

Gilead Sciences, Inc. (NASDAQ:GILD ) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 11:20 AM ET Company Participants Daniel P. O'Day - Chairman & CEO Conference Call Participants Salveen Jaswal Richter - Goldman Sachs Group, Inc., Research Division Salveen Jaswal Richter Great.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own TaskUs, Inc. ("TASK" or the "Company") (NASDAQ:TASK) stock purchased prior to May 9, 2025. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the proposed purchase of the company's outstanding Class A shares by an affiliate of Blackstone, the TaskUs Co-Founder and Chief Executive Officer Bryce Maddock, and TaskUs Co-Founder and President Jaspar Weir.

Union Pacific Corporation (NYSE:UNP ) Wells Fargo Industrials & Materials Conference June 10, 2025 10:30 AM ET Company Participants Jennifer L. Hamann - Executive VP & CFO Vincenzo James Vena - CEO & Director Conference Call Participants Christian F.

McDonald's stock was heading for its longest losing streak in 12 years after Redburn Atlantic recommended investors sell due to concerns over the impact of weight-loss drugs and relatively high prices.